http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006026533-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01d7935508cbe002beb151d4efde669
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_decff96397ed84fc165c73f45da3eaed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c13c95d01f0d2f1e5daf9f1b12d7298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e27c16508403279f403aae3ba45b4382
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-18
filingDate 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a2aea954357ce4f7444262cb55524f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ad45a139de82d6cf7c9f71d0cb5564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_572318377525c5c49036031c21c8ac84
publicationDate 2006-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006026533-A8
titleOfInvention Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors
abstract The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein. The compounds are propanol derivatives substituted by a cyclic amine.
priorityDate 2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 34.